Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Invitrogen™ Olaquindox metabolite Monoclonal Antibody (1A11)
GREENER_CHOICE

Catalog No. PIMA549674
Change view
Click to view available options
Quantity:
200 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
PIMA549674 200 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. PIMA549674 Supplier Invitrogen™ Supplier No. MA549674
Add to Cart
Add to Cart

Mouse Monoclonal Antibody

Antibody tested in indirect ELISA.

Olaquindox is a veterinary drug used to promote growth in livestock such as pigs and chickens. It has been banned in many countries due to its potential health risks to humans, including the potential for the development of antibiotic-resistant bacteria. Olaquindox is metabolized in the body into several different compounds, including 2-acetyl-1-methylimidazo[4,5-f]quinolone (AMIQ). AMIQ has been shown to be genotoxic, meaning it can damage DNA and potentially cause cancer.
TRUSTED_SUSTAINABILITY

Specifications

Antigen Olaquindox metabolite
Applications ELISA, Immunohistochemistry, Lateral Flow, SDS-Page
Classification Monoclonal
Clone 1A11
Concentration 6.6 mg/mL
Conjugate Unconjugated
Formulation PBS with 0.09% sodium azide; pH 7.4
Host Species Mouse
Immunogen Conjugate of MQCA hapten and KLH.
Purification Method Protein G
Quantity 200 μg
Regulatory Status RUO
Primary or Secondary Primary
Target Species Chemical
Content And Storage -20°C, Avoid Freeze/Thaw Cycles
Product Type Antibody
Form Liquid
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.